"However, Novo Nordisk, the pharmaceutical giant driving a weight-loss craze in the U.S., thinks the proposed changes will hurt innovation and drive the company toward the States at the expense of its Europe operations."

Read this story from "Fortune" for free without being tracked.

https://read.distractionfree.site/fortune/2023/11/06/novo-nordisk-europe-eu-us-new-rules-regulation/

#regulation #Ozempic #EFPIA #Wegovy #EU’s27 #Jørgensen #FinancialTimes